At 7.30 am today, dialysis patient Brian Pinker became the very first person to be vaccinated as part of the UK’s rollout of the Oxford / AstraZeneca coronavirus vaccine, ChAdOx1 nCoV-19, with patients at the Oxford University NHS Hospitals Trust becoming the first to receive this life-saving vaccine. The Oxford AstraZeneca vaccinations will be delivered […]
A world-first, AI powered, outcomes-driven, decision support tool – EchoGo Pro, has been cleared by the FDA and is now available to clinicians across the U.S. EchoGo Pro was trialed and validated in the UK and US, improving the diagnostic accuracy of clinicians for Coronary Artery Disease (CAD), the most common form of heart disease […]
The University of Oxford welcomes the news that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK. The Joint Committee on Vaccination and Immunisation (JCVI) will also publish its latest advice for the […]
Dr Bruno Holthof, Chief Executive of Oxford University Hospitals (OUH), has welcomed today’s announcement that the coronavirus vaccine developed by scientists at the University of Oxford has been approved for use in the UK. The UK Government today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the Oxford-AstraZeneca vaccine in […]
Ten leading academics from Oxford Brookes University have been appointed to panels for the Research Excellence Framework (REF) 2021. Named amongst over 400 members, assessors and specialist advisers, they will play a key role in assessing the wider impact of research in UK universities. The REF is the UK’s system for assessing the quality of […]
This strategy sets out our focus and priorities for the next 15 years. 7621_university_strategy2035V8 The Strategy has four Pillars: Education and Enterprise Research and Innovation People and Culture Partnerships and Place We have worked closely with our students, staff, local community and other stakeholders to create a new vision for Oxford Brookes University for 2020/2021 and […]
https://www.oxfordahsn.org/news-and-events/news/eight-ventures-pitch-for-investment/
A new institute for nanoscience research is to open in Oxford thanks to a $10 million gift from The Kavli Foundation. The new Kavli Institute for NanoScience Discovery (Kavli INSD) at Oxford will be a unique combination of structural biology with world-leading biochemistry, pathology, chemistry, physics, physiology and engineering. Based in a new building at […]
Oxford Brookes Business School is part of a new institute that will boost ground-breaking research to explore how to increase productivity, boost wages and support the economic recovery across the UK, backed by a £37 million government investment. The Productivity Institute is based at the University of Manchester and will identify barriers to increase productivity levels across […]
In Covid-19, inhaled budesonide may prevent damaging inflammation, stop the virus from getting into lung cells and inhibit viral replication. From 27 November 2020, the inhaled corticosteroid budesonide will be investigated as part of the UK’s national priority platform trial for Covid-19 treatments that can be taken at home. Led by the University of Oxford, […]